NSE filing, NSE: ETHOSLTD. Summary written from the filing by ALFA Finder's alert engine.
National Bank For Financing Infrastructure And Development: key numbers
- Share price
- ₹2,850.40
- Market cap
- ₹7,627 Cr
- Revenue (annual)
- ₹1,612 Cr
- Net profit (annual)
- ₹94.77 Cr
- P/E (TTM)
- 73.4×Sector 66.2×
- Promoter holding
- 50.59%+0.00% QoQ
- FII holding
- 8.85%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from National Bank For Financing Infrastructure And Development
All →Ethos Board Meeting Date
Ethos Ltd has scheduled a board meeting on November 12, 2026, to approve its Q2 and half-year results. The trading window remains closed for designated persons until 48 hours post-results declaration.
Ethos Capacity Expansion
Ethos has opened a new Ethos Summit boutique at Fort, Mumbai, taking its total to 105 boutiques across India. The filing is an update on a store opening with no monetary value disclosed.
- new boutiques
- 1.0 boutiques
Ethos Other Announcement
Ethos Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, pursuant to SEBI Listing Regulations.
Ethos Management Change
National Sales Head Mr. Rajesh Pandey has resigned from Ethos Limited. His departure is effective from October 5, 2026, to pursue other career opportunities.
Ethos Annual General Meeting
Ethos Ltd disclosed proceedings of its 19th AGM held on 15 Sep 2026. The meeting adopted FY26 financials and re-appointed the Chairman & WTD Mr. Yashovardhan Saboo.
Ethos Capacity Expansion
Ethos Limited has inaugurated a new watch boutique at Hilite Mall in Kozhikode, Kerala. The company now operates 104 boutiques across India.
- new retail store
- 1.0 boutiques
Other regulatory approval announcements
All →Sandur Manganese & Iron Ores Regulatory Approval
Sandur Manganese received environmental clearance to raise iron ore capacity to 9.42 MTPA. No rupee value is disclosed in the filing.
- iron ore RoM capacity
- 9.42 MTPA
Neogen Chemicals Regulatory Approval
Neogen Chemicals received GPCB's revocation of its Dahej plant direction and a CC&A amendment for manufacturing. The revocation is for three months with conditions attached.
Arihant Capital Markets Regulatory Approval
Arihant Capital Markets received SEBI in-principle approval to sponsor and set up a mutual fund. Final registration remains subject to SEBI's conditions.
Dr. Reddy's Laboratories Regulatory Approval
Dr. Reddy's Laboratories received marketing authorization from Brazil's ANVISA for its generic semaglutide injection. The approval targets Brazil's diabetes market, estimated at approximately USD 244.6 million.
Alembic Pharmaceuticals Regulatory Approval
Alembic Pharmaceuticals received USFDA final approval for its generic Olopatadine Hydrochloride Ophthalmic Solution 0.7% ANDA. The product's US market is estimated at $20 million, per IQVIA.
Emmbi Industries Regulatory Approval
SEBI exempted the Makrand and Rinku Appalwar business trusts from SAST takeover rules for an internal family share transfer. Control and promoter shareholding remain unchanged.